As part of a major cross-sectoral initiative under the Innovative Health Initiative Joint Undertaking (IHI JU), a pre-identified consortium of global pharmaceutical and medical technology leaders has been assembled to advance innovation, data-driven research, and digital transformation in healthcare.
Led by Pfizer, this strategic consortium will leverage collective expertise to address critical healthcare challenges and accelerate the development of smarter, more efficient solutions for patients and providers.
GenAIz joins this consortium as a key driver of AI-powered innovation, providing advanced technologies to support intelligent data management, process automation, and regulatory compliance across the ecosystem.
Consortium Members and Contributing Partners include:
- Pfizer (Lead Partner)
- GenAIz (AI Innovation Partner)
- AbbVie
- AstraZeneca
- F. Hoffmann-La Roche
- IQVIA
- Johnson & Johnson
- Mölnlycke
- Novartis
- Novo Nordisk
- Siemens Healthineers / Varian
- UCB
Together, these organizations will play a vital role in shaping the future of healthcare through collaboration, innovation, and next-generation technology.
